β-Arrestin 2 Mediates g protein-coupled receptor 43 signals to nuclear factor-κB

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 11, 2013, Pages 1754-1759

  Lee, Su Ui ^a   In, Hyun Ju ^a   Kwon, Mi So ^a,b   Park, Bi Oh ^a   Jo, Minmi ^c   Kim, Mun Ock ^a   Cho, Sungchan ^a,b   Lee, Sangku ^a   Lee, Hyun Jun ^a   Kwak, Young Shin ^c   Kim, Sunhong ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Korea University   (South Korea)

Author keywords

arrestin; G protein coupled receptor 43; Inflammation; Nuclear factor B

Indexed keywords

BETA ARRESTIN 2; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 43; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BETA ARR2 GENE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; INTERNALIZATION; LEUKOCYTE MIGRATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA TRANSPORT; SIGNAL TRANSDUCTION;

ARRESTINS; HEK293 CELLS; HELA CELLS; HUMANS; NF-KAPPA B; RECEPTORS, CELL SURFACE;

EID: 84888625872     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00312     Document Type: Article

References (28)

1. Cummings JH. Short chain fatty acids in the human colon. Gut, 22, 763-779 (1981).
2. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol., 40, 235-243 (2006).
3. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP. Butyrate inhibits inflammatory responses through NF-B inhibition: implications for Crohn's disease. Gut, 47, 397-403 (2000).
4. Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol., 13, 2826-2832 (2007).
5. Senga T, Iwamoto S, Yoshida T, Yokota T, Adachi K, Azuma E, Hamaguchi M, Iwamoto T. LSSIG is a novel murine leukocytespecific GPCR that is induced by the activation of STAT3. Blood, 101, 1185-1187 (2003).
6. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun., 303, 1047-1052 (2003).
7. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem., 278, 11312-11319 (2003).
8. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Di Yu, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461, 1282-1286 (2009).
9. Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A, Franke A, Ott S, Hasler R, Nikolaus S, Folsch UR, Rose-John S, Jiang HP, Li J, Schreiber S, Rosenstiel P. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol., 183, 7514-7522 (2009).
10. Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci., 115, 455-465 (2002).
11. Shenoy SK, Lefkowitz RJ. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J., 375, 503-515 (2003).
12. Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B, Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell, 14, 303-317 (2004).
13. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ. -Arrestin inhibits NF-B activity by means of its interaction with the NF-B inhibitor IB. Proc. Natl. Acad. Sci. U.S.A., 101, 8603-8607 (2004).
14. Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J, Jaeckel P, Ge H, Wang Y, Jiao X, Liu J, Kayser F, Tian H, Li Y. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol. Pharmacol., 74, 1599-1609 (2008).
15. Wang Y, Jiao X, Kayser F, Liu J, Wang Z, Wanska M, Greenberg J, Weiszmann J, Ge H, Tian H, Wong S, Schwandner R, Lee T, Li Y. The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. Bioorg. Med. Chem. Lett., 20, 493-498 (2010).
16. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. -Arrestin-dependent formation of 2 adrenergic receptor-Src protein kinase complexes. Science, 283, 655-661 (1999).
17. Reiter E, Lefkowitz RJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metab., 17, 159-165 (2006).
18. Hayden MS, Ghosh S. Signaling to NF-B. Genes Dev., 18, 2195- 2224 (2004).
19. Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, Zhu F, Liu J, Wang S, Monsma F, Vassileva G, Maguire M, Gustafson E, Bayne M, Chou CC, Lundell D, Jenh CH. Shortchain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J. Gastroenterol., 15, 5549-5557 (2009).
20. Vinolo MAR, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly-Y M, Stephens L, Hawkins PT, Curi R. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS ONE, 6, e21205 (2011).
21. Kim S, Kim YM, Kwak YS. A novel therapeutic target, GPR43; where it stands in drug discovery. Arch. Pharm. Res., 35, 1505- 1509 (2012).
22. Macia L, Thorburn AN, Binge LC, Marino E, Rogers KE, Maslowski KM, Vieira AT, Kranich J, Mackay CR. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol. Rev., 245, 164-176 (2012).
23. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. Differential affinities of visual arrestin, beta arrestin 1, and beta arrestin 2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem., 275, 17201-17210 (2000).
24. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, Nguyen DG, Caldwell JS, Chen YA. Lipid G protein-coupled receptor ligand identification using -arrestin PathHunter assay. J. Biol. Chem., 284, 12328-12338 (2009).
25. Hudson BD, Christiansen E, Tikhonova IG, Grundmann M, Kostenis E, Adams DR, Ulven T, Milligan G. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J., 26, 4951-4965 (2012).
26. Luan B, Zhang Z, Wu Y, Kang J, Pei G. Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. EMBO J., 24, 4237-4246 (2005).
27. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptorinterleukin 1 receptor signaling. Nat. Immunol., 7, 139-147 (2006).
28. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell, 142, 687-698 (2010).